by Stephan Schaller | Dec 19, 2024 | Events
Meet us at #FDA 2025 Free Hybrid Public Workshop on Pediatric Drug Development Safety and Novel Alternative Methods Our CEO, Dr. Stephan Schaller, is an invited speaker for a joint CERSi FDA workshop on the topic of “Pediatric Developmental Safety Assessment: Novel...
by Stephan Schaller | Dec 18, 2024 | Aktuell, Corporate
2024 - Thank You! A Year of Growth, Innovation, and Impact at ESQlabs. Seasonal poem: “May your walls know joy, may every room hold laughter, and every window open to great possibility.” –Mary Anne Radmacher As we close another significant year, we celebrate...
by Stephan Schaller | Dec 10, 2024 | Aktuell
A New joint Initiative to Advance Women’s Health and Tuberculosis Therapies in Regions with Constrained Healthcare Resources ESQlabs GmbH, is pleased to announce a pioneering open-source model-informed drug development (MIDD) project focused on enhancing treatments...
